Company record
Radnostix
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about Radnostix.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 1 | Class III | Radnostix Drug |
Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphate Capsules 300 mg, International Isotopes Inc., Idaho Falls, ID 83401. NDC: 69208-003-15; 69208-003… Failed Tablet/Capsule Specifications FDA notice D-0401-2026 |
| Mar 11 | Class II | Radnostix Drug |
Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order … Presence of Particulate Matter: Due to production issues FDA notice D-0389-2026 |